Hassan Bukhari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hassan Bukhari has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Thorsten Müller
Department of Molecular Biochemistry, Cell Signalling, Ruhr-University Bochum, Bochum, Germany
5 shared publications Christina Loosse
Cell Signaling in Neurodegeneration, Medical Proteome-Center, Ruhr-University Bochum, Universitätsstr. 150, 44801 Bochum, Germany
4 shared publications- Gregor Leonhardt
Leibniz Research Center for Working Environment and Human Factors, Dortmund, Germany
3 shared publications Katharina Kolbe
Institute of Psychiatric Phenomics and Genomics, Clinical Center of the University of Munich, Nussbaumstr. 7, 80336 Munich, Germany; Department of Molecular Biochemistry, Faculty of Chemistry and Biochemistry, Ruhr University Bochum, Universitätsstr. 150, 44780, Bochum, Germany
3 shared publicationsAnnika Glotzbach
Cell Signaling in Neurodegeneration, Medical Proteome-Center, Ruhr-University Bochum, Universitätsstr. 150, 44801 Bochum, Germany
2 shared publicationsKatrin Marcus
Functional Proteomics, Medical Proteome-Center, Ruhr-University Bochum, Universitätsstr. 150, 44801 Bochum, Germany
2 shared publications
Latest Publications
- 1 November 2019
- Published by Elsevier in Trends in Cell Biology
- Vol. 29 (11) , 912-928
Endogenous Fluorescence Tagging by CRISPR
- 1 November 2019
- Published by Elsevier in Trends in Cell Biology
- Vol. 29 (11) , 912-928
Endogenous Fluorescence Tagging by CRISPR
- Open Access
- 29 May 2019
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (5) , e0217269
A novel understanding of postoperative complications: In vitro study of the impact of propofol on epigenetic modifications in cholinergic genes
Propofol is a widely used anaesthetic drug with advantageous operating conditions and recovery profile. However, propofol could have long term effects on neuronal cells and is associated with post-operative delirium (POD). In this context, one of the contributing factors to the pathogenesis of POD is a reduction of cholinesterase activity. Accordingly, we investigated the effects of propofol on the methylation, expression and activity of cholinergic genes and proteins in an in-vitro model. We found that propofol indeed reduced the activity of AChE / BChE in our in-vitro model, without affecting the protein levels. Furthermore, we could show that propofol reduced the methylation of a repressor region of the CHRNA7 gene without changing the secretion of pro–or anti-inflammatory cytokines. Lastly, propofol changed the expression patterns of genes responsible for maintaining the epigenetic status of the cell and accordingly reduced the tri-methylation of H3 K27. In conclusion we found a possible functional link between propofol treatment and POD, due to a reduced cholinergic activity. In addition to this, propofol changed the expression of different maintenance genes of the epigenome that also affected histone methylation. Thus, propofol treatment may also induce strong, long lasting changes in the brain by potentially altering the epigenetic landscape.
- 29 May 2019
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (5) , e0217269
Open AccessA novel understanding of postoperative complications: In vitro study of the impact of propofol on epigenetic modifications in cholinergic genes
Propofol is a widely used anaesthetic drug with advantageous operating conditions and recovery profile. However, propofol could have long term effects on neuronal cells and is associated with post-operative delirium (POD). In this context, one of the contributing factors to the pathogenesis of POD is a reduction of cholinesterase activity. Accordingly, we investigated the effects of propofol on the methylation, expression and activity of cholinergic genes and proteins in an in-vitro model. We found that propofol indeed reduced the activity of AChE / BChE in our in-vitro model, without affecting the protein levels. Furthermore, we could show that propofol reduced the methylation of a repressor region of the CHRNA7 gene without changing the secretion of pro–or anti-inflammatory cytokines. Lastly, propofol changed the expression patterns of genes responsible for maintaining the epigenetic status of the cell and accordingly reduced the tri-methylation of H3 K27. In conclusion we found a possible functional link between propofol treatment and POD, due to a reduced cholinergic activity. In addition to this, propofol changed the expression of different maintenance genes of the epigenome that also affected histone methylation. Thus, propofol treatment may also induce strong, long lasting changes in the brain by potentially altering the epigenetic landscape.
- 1 September 2017
- Published by Elsevier in Progress in Neurobiology
- Vol. 156, 189-213
Small things matter: Implications of APP intracellular domain AICD nuclear signaling in the progression and pathogenesis of Alzheimer’s disease
- 1 September 2017
- Published by Elsevier in Progress in Neurobiology
- Vol. 156, 189-213
Small things matter: Implications of APP intracellular domain AICD nuclear signaling in the progression and pathogenesis of Alzheimer’s disease
- 1 December 2016
- Published by Elsevier in Neurobiology of Aging
- Vol. 48, 103-113
Extensive nuclear sphere generation in the human Alzheimer's brain
- 1 December 2016
- Published by Elsevier in Neurobiology of Aging
- Vol. 48, 103-113
Extensive nuclear sphere generation in the human Alzheimer's brain
- 14 August 2016
- Published by Elsevier in Cellular Signalling
- Vol. 28 (11) , 1725-1734
Membrane tethering of APP c-terminal fragments is a prerequisite for T668 phosphorylation preventing nuclear sphere generation
- 14 August 2016
- Published by Elsevier in Cellular Signalling
- Vol. 28 (11) , 1725-1734
Membrane tethering of APP c-terminal fragments is a prerequisite for T668 phosphorylation preventing nuclear sphere generation
- 1 January 2016
- Published by Elsevier in Cellular Signalling
- Vol. 28 (1) , 100-109
Nuclear spheres modulate the expression of BEST1 and GADD45G
- 1 January 2016
- Published by Elsevier in Cellular Signalling
- Vol. 28 (1) , 100-109
Nuclear spheres modulate the expression of BEST1 and GADD45G